An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
Status:
Terminated
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects (good and bad) of golimumab (CNTO 148)
therapy in participants with active ulcerative colitis (UC) (sores in the colon).